The Global Gene Editing Market is growing with the rapid pace; mainly due to the technological advancement in the healthcare sector. According to a recent study report published by the Market Research Future, The global market of Gene Editing Market is booming and expected to gain prominence over the forecast period. The global market of Gene Editing is forecasted to demonstrate a spectacular growth by 2024, surpassing its previous growth records in terms of value with a striking CAGR during the estimated period (2016 – 2024).
Gene Editing has generated a lot of excitement in academia and drug development. Its promises are two-fold: the unique ability to correct genetic mutations that may cause disease; and its utility in creating and controlling genetic information within patient cells. Emerging science suggests that permanently fixing or “editing” mutated cells or creating safer and more potent cell-based products with this technology could provide curative, one-time treatments for patients suffering from a broad range of diseases.
Gene Editing has various applications such as HIV would be cured by destroying the gene for CCR5. Some researchers are doing experiment and exploring the possibility of using Gene Editing to make heritable changes.
The new technology CRISPR is showing good results in this market. CRISPR is becoming an increasingly routine practice in the world of agriculture. For instance, introduction of mutations or other genetic changes into plants can enhance breeding of certain crops such as rice and wheat. But CRISPR can work beyond improving crops; it has the potential to manipulate mammalian genomes for therapeutic purposes.
Global Gene Editing Market – Key Players
GenScript USA Inc. (U.S.), Horizon Discovery Group plc (U.K.), Integrated DNA Technologies, Inc. (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), OriGene Technologies, Inc. (U.S.), Sangamo Biosciences, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.).
Get Free Sample Report @ https://www.marketresearchfuture.com/sample_request/707
Industry News:
Thermo Fisher Scientific Inc. an American international biotechnology company founded in 2006 by the merger of Thermo Electronic and Fisher Scientific. In Feb 2014, the company announced the complete acquisition of Life Technology Corp for USD 76.13 Billion. Life Technology Corp is a global leading player in genetic testing and precision laboratory equipment. New instruments in Gene editing technology are Ion S5 sequencing systems, Sanger sequencing, QuantStudio family, QuantiGene Plex Assay, QuantiGene Singleplex Assay and QuantiGene Singleplex HT Assay. This acquisition will help the company create unrivalled control in serving research, life sciences, specialty diagnostics and applied markets.
Global Gene Editing Market – Segmentation
To give the insight information on Global Gene Editing Market report, MRFR has segment the report in to 4 key dynamics –
Segmentation By Methods: Comprises Crispr, Talen, ZFN, Antisense technology and other.
Segmentation By End-Users: Comprises biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs).
Segmentation By Applications: Comprises Plant genetic engineering, cell line engineering, animal genetic engineering, plant genetic engineering and other.
Segmentation By Regions: Comprises Geographical regions – North America, Europe, APAC and Rest of the World.
Global Gene Editing Market – Regional Analysis
The regional analysis comprises of North America, Europe, Asia Pacific, Middle East and rest of the world. The Gene Editing market is dominated by North America due to the strong growth trend in the pharmaceuticals and biotechnology industries and is followed by Europe. The North American meat industry is among the largest in the world followed by European and Asia Pacific region. The crop and cattle industry form the largest consumer of genome engineering services in the region, followed by equine, and canine breeding industry.
The Asian region is showing good opportunities in Gene Editing market due to the expansion of leading genome editing companies and increased R&D spending. Emerging economies of Asia Pacific and Latin America are expected to show significant growth in the Gene Editing market due to an increase in the number of laboratories in these regions and development of existing ones for automation of various instrumentation systems. Also, the pharmaceutical industries are also rapidly increasing which is also driving the Gene Editing market in Asia region.
Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/gene-editing-market-707
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/gene-editing-market-707